The factsheet has been successfully sent.
Please check your inbox.
Please fill in the form to receive the factsheet directly into your inbox

You have items in your inquiry list.
Inquire now?

22 November 2022 [Press release]

GenoFlow™ HPV Array 100% Proficient in latest QCMD EQA Programme (November 2022)

The QCMD (Quality Control for Molecular Diagnostics, is an independent International External Quality Assessment (EQA) / Proficiency Testing (PT) organisation. QCMD provides a wide-ranging quality assessment service primarily focused on molecular infectious diseases to over 2000 participants in over 100 countries. Their Human Papillomavirus (Preservcyt) EQA Programme assesses the proficiency of laboratories in the detection of different high risk HPV types within a PreservCyt® matrix.

In the latest November 2022 programme, laboratory using DiagCor’s GenoFlowTM HPV Array, together with DiagPuroTM Nucleic Acid Extraction System and DiagPuroTM Viral DNA/RNA Extraction Reagent has participated and attained fully proficient (100% proficient) status. In addition to the HPV subtypes covered by the proficiency programme, GenoFlowTM HPV Array Test Kit can genotype a total of 33 high- and low-risk HPV subtypes. DiagCor Life Science prioritizes high product quality and actively supports HPV genotyping services in laboratories worldwide.

Find the full details of the kit on the product page, or get in touch to learn more!


About DiagCor

Headquartered in Hong Kong with ISO 13485 accredited Quality Management System, DiagCor has been dedicated solely to molecular diagnostics (MDx) since 2006. The global leader in flow-through hybridization technology, the company offers a range of products, solutions and services related to RNA and DNA analysis. As well as providing MDx laboratory services to Asia Pacific practitioners, DiagCor develops and manufactures MDx products and solutions, and offers MDx medical translation services and MDx consulting.

Press Contact

DiagCor Life Science

[email protected]